BRT Biotechnologies, Inc.
BRT Biotechnologies provides high-quality macrocycle libraries using its proprietary BRiTeCycle® platform to advance drug discovery and enable rapid identification of promising drug leads for treating hard-to-drug targets.
Funding history
About BRT Biotechnologies, Inc.
How much funding has BRT Biotechnologies, Inc. raised?
BRT Biotechnologies, Inc. has raised $1.0M in total funding. The most recent round was Series A.
Where is BRT Biotechnologies, Inc. headquartered?
BRT Biotechnologies, Inc. is headquartered in Claremont, CA.
What does BRT Biotechnologies, Inc. do?
BRT Biotechnologies provides high-quality macrocycle libraries using its proprietary BRiTeCycle® platform to advance drug discovery and enable rapid identification of promising drug leads for treating hard-to-drug targets.
What makes BRT Biotechnologies, Inc. notable?
BRT Biotechnologies was co-founded by CEO Jane Liu, a tenured professor, and LA-based biotech operator Gregory Copeland, and counts StoryHouse Ventures and Springboard Enterprises among its investors.
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
